Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-25-002139
Filing Date
2025-03-31
Accepted
2025-03-31 17:11:45
Documents
57
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR DEC 2024 cns_i10k-123124.htm   iXBRL 10-K 997883
2 DESCRIPTION OF SECURITIES OF CNS PHARMACEUTICALS, INC. cns_ex0401.htm EX-4.1 21571
3 INSIDER TRADING POLICY cns_ex1901.htm EX-19.1 59304
4 CONSENT OF MALONEBAILEY LLP cns_ex2301.htm EX-23.1 2751
5 CERTIFICATION cns_ex3101.htm EX-31.1 9564
6 CERTIFICATION cns_ex3102.htm EX-31.2 9657
7 CERTIFICATION cns_ex3201.htm EX-32.1 3498
8 CERTIFICATION cns_ex3202.htm EX-32.2 3379
  Complete submission text file 0001683168-25-002139.txt   5105725

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE cnsp-20241231.xsd EX-101.SCH 32547
10 XBRL CALCULATION FILE cnsp-20241231_cal.xml EX-101.CAL 33576
11 XBRL DEFINITION FILE cnsp-20241231_def.xml EX-101.DEF 174442
12 XBRL LABEL FILE cnsp-20241231_lab.xml EX-101.LAB 345057
13 XBRL PRESENTATION FILE cnsp-20241231_pre.xml EX-101.PRE 294207
59 EXTRACTED XBRL INSTANCE DOCUMENT cns_i10k-123124_htm.xml XML 553336
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39126 | Film No.: 25794895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)